Page last updated: 2024-08-24

plerixafor and Experimental Leukemia

plerixafor has been researched along with Experimental Leukemia in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bridger, G; DiPersio, JF; Holt, MS; Ley, TJ; Nervi, B; Piwnica-Worms, D; Prior, JL; Ramirez, P; Rettig, MP; Ritchey, JK; Uy, GL	1
Bornhäuser, M; Brenner, S; Jacobi, A; Koch, S; Lehmann, R; Malech, HL; Müller, K; Ryser, M; Thiede, C; Thieme, S; Ugarte, F	1

Other Studies

2 other study(ies) available for plerixafor and Experimental Leukemia

Article	Year
Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100. Blood, 2009, Jun-11, Volume: 113, Issue:24 Topics: Animals; Anti-HIV Agents; Antimetabolites, Antineoplastic; Apoptosis; Benzylamines; Bone Marrow; Cathepsin G; Cathepsins; Colony-Forming Units Assay; Cyclams; Cytarabine; Drug Synergism; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cells; Heterocyclic Compounds; Leukemia, Experimental; Leukemia, Promyelocytic, Acute; Mice; Mice, Inbred C57BL; Protein Transport; Receptors, CXCR4; Serine Endopeptidases; Stromal Cells; Tumor Cells, Cultured	2009
Impact of CXCR4 inhibition on FLT3-ITD-positive human AML blasts. Experimental hematology, 2010, Volume: 38, Issue:3 Topics: Acute Disease; Animals; Benzylamines; Bone Marrow Cells; Cell Movement; Cell Proliferation; Cells, Cultured; Coculture Techniques; Cyclams; Flow Cytometry; fms-Like Tyrosine Kinase 3; Hematopoietic Stem Cells; Heterocyclic Compounds; Humans; Leukemia, Experimental; Leukemia, Myeloid; Mice; Mice, Inbred NOD; Mice, SCID; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mutation; Phosphorylation; Receptors, CXCR4; Reverse Transcriptase Polymerase Chain Reaction; STAT3 Transcription Factor; STAT5 Transcription Factor; Transplantation, Heterologous; Tumor Suppressor Proteins	2010

Article

Year

Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100.

Blood, 2009, Jun-11, Volume: 113, Issue:24

Topics: Animals; Anti-HIV Agents; Antimetabolites, Antineoplastic; Apoptosis; Benzylamines; Bone Marrow; Cathepsin G; Cathepsins; Colony-Forming Units Assay; Cyclams; Cytarabine; Drug Synergism; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cells; Heterocyclic Compounds; Leukemia, Experimental; Leukemia, Promyelocytic, Acute; Mice; Mice, Inbred C57BL; Protein Transport; Receptors, CXCR4; Serine Endopeptidases; Stromal Cells; Tumor Cells, Cultured

2009

Impact of CXCR4 inhibition on FLT3-ITD-positive human AML blasts.

Experimental hematology, 2010, Volume: 38, Issue:3

Topics: Acute Disease; Animals; Benzylamines; Bone Marrow Cells; Cell Movement; Cell Proliferation; Cells, Cultured; Coculture Techniques; Cyclams; Flow Cytometry; fms-Like Tyrosine Kinase 3; Hematopoietic Stem Cells; Heterocyclic Compounds; Humans; Leukemia, Experimental; Leukemia, Myeloid; Mice; Mice, Inbred NOD; Mice, SCID; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mutation; Phosphorylation; Receptors, CXCR4; Reverse Transcriptase Polymerase Chain Reaction; STAT3 Transcription Factor; STAT5 Transcription Factor; Transplantation, Heterologous; Tumor Suppressor Proteins

2010